The combination of PEG interferon (IFN)-α-2a [Pegasys] plus ribavirin [Copegus] was more effective than IFN-α-2a plus ribavirin in the treatment of hepatitis C virus (HCV) infections in patients coinfected with HIV, according to a study presented at the 11th Conference on Retroviruses and...
The present invention provides the use of PEG-IFN-alpha conjugates in association with ribavirin for the treatment of chronic hepatitis B infections. The present invention also provides a method for treating chronic hepatitis B infections in patients in need of such treating comprising administering an...
PEG IFN-alpha-2a + ribavirin for hepatitis C: less impact on QOLHepatitis-C, treatmentInterferon-alpha-2b, therapeutic usePEG-interferon-alpha-2a, therapeutic useQuality-of-lifeRibavirin, therapeutic use
1. PEG-IFNalpha2a +リバビリン療法施行中にB型慢性肝炎の急性増悪を起こしたB型C型重複感染の1例 [J] . 宮田央, 宮田學, 工藤正俊 肝脏. 2012,第12期 机译:一例B型C多发感染,在PEG-IFNα2a+利巴韦林治疗期间引起慢性乙型肝炎急性加重 2. ぺグィンターフェロン,リバビリン,シメプレビル3...
Patient was advised for PEG-IFNalpha- 2a combination therapy for 24 weeks, to which he responded well after 4 week and showed sustained virologic response after 06 months of completion of therapy. His IL-8 and TNF-alpha levels also came to lower levels after treatment with PEG-IFN-alpha 2a...
Results at week 12 of the trial show that those HCV genotype 1 and 4 patients given 180µg of PegIFN-lambda achieved RVR 14.7% of the time and cEVR 55.9% of time, compared to 5.8% RVR and 37.9% cEVR in patients given the same dose of PegIFN-alpha-2a. ...
Results at week 12 of the trial show that those HCV genotype 1 and 4 patients given 180µg of PegIFN-lambda achieved RVR 14.7% of the time and cEVR 55.9% of time, compared to 5.8% RVR and 37.9% cEVR in patients given the same dose of PegIFN-alpha-2a. ...
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006;44:728-735.Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, Pham BN, Maylin S, Bedossa P, Deny P, Marcellin ...
Discusses the results of a phase III study presented at the Annual Conference of the Japan Society of Hepatology in Osaka, Japan, as of June 25, 2005, regarding the efficacy of combination therapy with PEG interferon (IFN)-伪-2a plus ribavirin for the treatment of patients with hepatitis C ...
Yada N, Kudo M, Chung H, Hayaishi S, Takita M, Ueda T, et al. PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate. Intervirology 2010; 53:60-5....